Loading...

α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage

BACKGROUND: ABT-126 is a novel, safe and well-tolerated α7 nicotinic receptor agonist in a Phase 2 Alzheimer's disease study. Here we test the antidyskinetic effect of ABT-126 in MPTP-treated squirrel monkeys with moderate and more severe nigrostriatal damage. METHODS: Monkeys (n=21, Set 1) wer...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mov Disord
Main Authors: Zhang, Danhui, McGregor, Matthew, Bordia, Tanuja, Perez, Xiomara A., McIntosh, J. Michael, Decker, Michael W., Quik, Maryka
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4715565/
https://ncbi.nlm.nih.gov/pubmed/26573698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26453
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!